In recent years, PSMA has become a preferred target for positron emission tomography (PET) imaging and radionuclide therapy for PCa, with high sensitivity and specificity for PCa detection or localization [8, 9]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.